22. T. Kim, J. Davis, A. J. Zhang, X. He, and S. T. Mathews, «Curcumin Activates AMPK and Suppresses Gluconeogenic Gene Expression in Hepatoma Cells»,
23. Nafiseh Khandouzi, F. Shidfar, A. Rajab, T. Rahideh, P. Hosseini, and M. Mir Taheri, «The Effects of Ginger on Fasting Blood Sugar, Hemoglobin A1c, Apolipoprotein B, Apolipoprotein A-I and Malondialdehyde in Type 2 Diabetic Patients»,
24. L. Nogara, N. Naber, E. Pate, M. Canton, C. Reggiani, and R. Cooke, «Piperine’s Mitigation of Obesity and Diabetes Can Be Explained by Its Up-Regulation of the Metabolic Rate of Resting Muscle»,
ГЛАВА 8.
1. Maciej Gasior, Michael A. Rogawski, and Adam L. Hartman, «Neuroprotective and Disease-Modifying Effects of the Ketogenic Diet»,
2. Alzheimer’s Association, «2018 Alzheimer’s Disease Facts and Figures», https: / / www.alz.org / media / Documents / alzheimers-facts-and-figures-infographic.pdf.
3. Ibid.
4. World Health Organization, «Dementia: Key Facts», http: / / www.who.int / news
-room / fact-sheets / detail / dementia.5. Fanfan Zheng, L. Yan, Z. Yang, B. Zhong, W. Xie, «HbA1c, Diabetes and Cognitive Decline: The English Longitudinal Study of Aging»,
6. Yang An, V. R. Varma, S. Varma, et al., «Evidence for Brain Glucose Dysregulation in Alzheimer’s Disease»,
7. Ingrid Van der Auwera, Stefaan Wera, Fred Van Leuven, and Samuel T. Henderson, «A Ketogenic Diet Reduces Amyloid Beta 40 and 42 in a Mouse Model of Alzheimer’s Disease»,
8. Matthew K. Taylor et al., «Feasibility and Efficacy Data from a Ketogenic Diet Intervention in Alzheimer’s Disease»,
9. Rosebud O. Roberts, L. A. Roberts, Y. E. Geda, et al., «Relative Intake of Macronu– trients Impacts Risk of Mild Cognitive Impairment or Dementia»,
10. Steven C. Vlad et al., «Protective Effects of NSAIDs on the Development of Alzheimer Disease»,
11. Markus Bock, Andreas Michalsen, and Friedemann Paul, «Ketogenic Diet and Prolonged Fasting Improve Health-Related Quality of Life and Lipid Profiles in Multiple Sclerosis – A Randomized Controlled Trial» (Conference Paper, ECTRIMS 2015, Barcelona, October 2015).
12. T. E. Cullingford, «The Ketogenic Diet; Fatty Acids, Fatty Acid-Activated Receptors and Neurological Disorders»,
13. Mithu Storoni and Gordon T. Plant, «The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis»,
14. T. B. VanItallie, C. Nonas, A. Di Rocco, K. Boyar, K. Hyams, and S. B. Heymsfield, «Treatment of Parkinson Disease with Diet-Induced Hyperketonemia: A Feasibility Study»,
15. O. El-Rashidy, F. El-Baz, Y. El-Gendy, R. Khalaf, D. Reda, and K. Saad, «Ketogenic Diet versus Gluten Free Casein Free Diet in Autistic Children: A Case-Control Study»,
16. E. C. Bostrok, Kenneth C. Kirkby, and Bruce V. M. Taylor, «The Current Status of the Ketogenic Diet in Psychiatry»,
17. C. Di Lorenzo, G. Coppola, G. Sirianni, et al., «Migraine Improvement during Short Lasting Ketogenesis: A Proof-of-Concept Study»,
18. Cherubino Di Lorenzo, Gianluca Coppola, Davide Di Lenola, et al., «Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm Clinical Trial»,
19. Justin Sonnenburg and Erica Sonnenburg, «Gut Feelings – the ‘Second Brain’ in Our Gastrointestinal Systems»,